Arkolith/Insider Trading/TARS/Form 4

Whitfield Dianne C.

Chief Human Resources OfficerTarsus Pharmaceuticals, Inc. (TARS) · full profile →Form 4 · filed Mar 19, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$839K
Net Open-Market Flow
-$839K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 19, 2026Sell(S)4K$67.00$280K35K
Mar 18, 2026Sell(S)4K$68.71$280K39K
Mar 17, 2026Sell(S)4K$69.42$280K43K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001839516-26-000009) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML